Comprehensive Study Notes on Hyperglycemic Emergencies: Diabetic Ketoacidosis (DKA) and Hyperglycemic Hyperosmolar State (HHS)

Overview of Hyperglycemic Emergencies (DKA and HHS)

• Diabetic Ketoacidosis (DKA) and Hyperglycemic Hyperosmolar State (HHS) are acute metabolic emergencies associated with Diabetes Mellitus.

• Both conditions represent states of severe hyperglycemia resulting from insulin deficiency.

• They are considered different manifestations along the same spectrum of severe hyperglycemia rather than entirely separate diseases.

• Risk Profiles Based on Diabetes Type:

  • Type 1 Diabetes: Typically characterized by a state of absolute insulin deficiency, placing patients at a high risk for DKA.

  • Type 2 Diabetes: Characterized by a relative insulin deficiency, which predisposes patients to HHS.

Clinical Manifestations and Symptoms

• Shared Hallmark Features:

  • Polyuria (excessive urination).

  • Polydipsia (excessive thirst).

  • Dehydration: These symptoms are directly related to the osmotic diuretic effect of glucose, which pulls water from the body into the urine.

  • Lethargy and reduced level of consciousness: These relate to significant biochemical abnormalities as well as states of hypovolemia and dehydration.

• DKA-Specific Manifestations:

  • Altered Respiration: Patients exhibit "air hunger" or deep breathing, previously known as Kussmaul respiration. This is a compensatory mechanism used by the body to blow off excess $CO_2$ in an attempt to correct the underlying metabolic acidosis.

  • Gastrointestinal Symptoms: Abdominal pain and other GI symptoms may be present. These are postulated to occur due to altered gastrointestinal motility caused by the specific biochemical abnormalities of DKA.

Differentiating DKA and HHS (Biochemical and Clinical Comparison)

• Speed of Onset:

  • DKA: Occurs rapidly, typically over a period of hours.

  • HHS: Typically insidious and may develop over several days, sometimes associated with significant weight loss.

• Severity of Dehydration:

  • HHS is associated with more severe hypovolemia and profound dehydration compared to DKA.

• Mortality Rates:

  • HHS has a higher mortality rate than DKA. Contributing factors include the extent of dehydration and hypovolemia, as well as the older demographic typically affected by HHS.

• Biochemical Characteristics:

  • Hyperglycemia: Present in both, but typically more severe in HHS.

  • Acidosis (DKA): Characterized by a venous pH < 7.3.

  • Ketosis (DKA): Defined by ketone levels of > 3 (measured in blood or urinalysis).

  • Status in HHS: Typically lacks acidosis (venous pH > 7.3) and lacks significant ketone production (ketones < 3).

  • Osmolarity (HHS): The hallmark feature is hyperosmolarity, defined by a serum osmolarity of > 320\,mOsm/kg.

Essential Clinical Formulae

• Anion Gap:

  • Used to indicate the presence of unmeasured anions responsible for metabolic acidosis.

  • DKA is characterized by a high anion gap metabolic acidosis (HAGMA), where the high gap is caused by the presence of circulating ketones.

• Serum Osmolarity:

  • Measures the concentration of solutes in the serum.

  • It serves as a critical indicator of the degree of intravascular fluid deficit.

  • Significant hyperosmolarity is the primary metabolic feature in HHS.

Pathophysiology of DKA and HHS

• DKA Pathophysiology (Absolute Insulin Deficiency):

  1. The enzyme lipase in adipose tissue becomes active in the absence of insulin.

  2. Lipase results in the breakdown of triglycerides into glycerol.

  3. Glycerol is then converted into free fatty acids (FFAs).

  4. FFAs mobilize to the liver where they undergo oxidation to form ketone bodies.

  5. This final oxidation step occurs under the influence of glucagon.

  6. The circulating ketone bodies serve as a maladaptive alternate energy source, leading to hyperketonemia and acidemia (acidosis).

• HHS Pathophysiology (Relative Insulin Deficiency):

  1. Relative insulin deficiency leads to the mobilization of amino acids and the breakdown of muscle tissue.

  2. Amino acids promote an increase in glycogenolysis (breakdown of glycogen) and gluconeogenesis (formation of new glucose) in the liver.

  3. This massive production of glucose compounds hyperglycemia.

  4. Severe hyperglycemia causes profound osmotic diuresis, leading to the hallmark state of extreme dehydration and hypovolemia.

Principles of Ketogenesis

• Function: Ketone bodies serve as an alternate energy source, particularly for the brain when glucose cannot be utilized efficiently due to lack of insulin.

• Regulation: Glucagon is the key hormone promoting the final step of converting fatty acids to ketone bodies.

• Composition: Ketones are a collective group consisting of three different molecules.

• Systemic Effects: In addition to causing acidosis, ketones also contribute to osmotic diuresis.

Broad Management Principles

• Fluid Replacement: This is the most critical first step, involving aggressive resuscitation with intravenous (IV) fluids.

• Insulin Administration: Administered intravenously with the goal of slowly normalizing serum glucose. In DKA, insulin is also essential for ketone clearance.

• Electrolyte Management (Potassium):

  • DKA involves a total body potassium deficit due to urinary loss from osmotic diuresis.

  • Initial serum potassium ($K^+$) may appear normal or even high due to a shift from intracellular to extracellular spaces.

  • Initiating insulin and fluid treatment causes a rapid shift of potassium back into the cells (extracellular to intracellular), which can lead to a dangerous drop in circulating potassium levels.

  • Potassium supplementation must be initiated early in the management of DKA.

• Underlying Cause Identification: Patients must be thoroughly investigated to find and reverse the precipitating factor of the hyperglycemic emergency.

Etiology and Precipitating Factors

• Nonadherence: The most common cause is the patient not adhering to their prescribed medication or insulin regimen.

• Infection/Illness: Intercurrent illnesses or acute stressful events can trigger hyperglycemia.

• New Diagnosis: DKA or HHS may be the initial presentation for someone with previously undiagnosed Type 1 or Type 2 diabetes.

• Medications:

  • SGLT2 Inhibitors: Used in Type 2 diabetes, these drugs inhibit glucose reabsorption in the renal tubule. They can cause "euglycemic DKA," where ketones are produced despite relatively normal blood sugar levels, especially during starvation, surgery, or acute illness.

  • Atypical Antipsychotics: Medications like Risperidone and Olanzapine are associated with DKA risks.

  • Glucocorticoids: Medications like Prednisone can induce hyperglycemic emergencies via complex metabolic mechanisms.

Prevention and Risk Reduction Strategies

• Glycemic Control: Improving overall control through medication modification or insulin dose titration.

• Education: Programs to help patients take control of their condition.

• Sick Day Management (Specifically for Type 1 Diabetes):

  • Instructions on when to monitor ketone levels.

  • Guidelines on how and when to alter insulin doses during stress or illness.

  • A structured plan for managing acute hyperglycemia.

  • Clear criteria for when the patient must seek urgent medical attention based on early symptoms of DKA.

Questions & Discussion

• Question: Compared to DKA, HHS A) occurs rapidly, B) has a lower mortality, C) is associated with more severe hypovolemia, D) is associated with significant ketone production, E) all of the above.

  • Answer: Option C is correct. HHS has a higher mortality, lacks significant ketones, is usually insidious (not rapid), and is characterized by extreme hypovolemia.

• Question: Regarding ketogenesis, which is true? A) Ketones are an alternate energy source, B) Glucagon promotes fatty acid conversion to ketones, C) Ketones are a group of three molecules, D) Ketones promote osmotic diuresis, E) All of the above.

  • Answer: Option E is correct. All statements accurately describe the properties and functions of ketones.

• Question: Which of the following statements is correct? A) DKA and HHS are not mutually exclusive, B) Patients with Type 2 diabetes can develop DKA, C) Mortality is higher in HHS, D) Initial treatment in HHS involves fluids followed by insulin, E) All of the above.

  • Answer: Option E is correct.

  • Detail on A & B: DKA and HHS are on a spectrum and can overlap. Type 2 patients can develop DKA, particularly in cases of severe infection or when using SGLT2 inhibitors.

  • Detail on D: In HHS, reversing the profound hypovolemia with fluids is the priority before starting insulin.